Grisanti Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Grisanti Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,597	Closed	-$3.44M	–	58
2019 Q4	$3.44M	Sell	10,597 -72	-0.7%	-$21.8K	1.66%	25
2019 Q3	$3.11M	Buy	10,669 +26	+0.2%	+$7.45K	1.7%	24
2019 Q2	$3.13M	Sell	10,643 -107	-1%	-$29.5K	1.71%	25
2019 Q1	$2.94M	Sell	10,750 -8,930	-45%	-$2.22M	1.79%	25
2018 Q4	$4.4M	Sell	19,680 -4,213	-18%	-$988K	2.86%	12
2018 Q3	$5.83M	Sell	23,893 -4,284	-15%	-$986K	2.87%	12
2018 Q2	$5.84M	Sell	28,177 -145	-0.5%	-$30.8K	2.54%	17
2018 Q1	$5.85M	Sell	28,322 -713	-2%	-$150K	2.68%	17
2017 Q4	$5.51M	Buy	+29,035	New	+$5.56M	2.26%	21

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Grisanti Capital Management's TMO Position: Q1 2020 in Review

Grisanti Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 10,597 shares — an estimated $3.44M sold.

Grisanti Capital Management first reported a position in TMO in Q4 2017 and held it in 9 quarters. The position peaked at $5.85M in Q1 2018. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

Grisanti Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
Grisanti Capital Management sold 10,597 Thermo Fisher Scientific shares in Q1 2020, an estimated $3.44M.
Grisanti Capital Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 9 quarters.
Grisanti Capital Management's Thermo Fisher Scientific position peaked at $5.85M in Q1 2018.
1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Grisanti Capital Management's 13F filing for Q1 2020, filed 6 May 2020.